Angiogenesis in chronic liver disease and its complications: Angiogenesis in CLD

Tumor angiogenesis: therapeutic implications

Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · see citing works

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885 · see citing works

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · see citing works

Angiogenesis in health and disease

Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,258 · see citing works

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288 · see citing works

Modes of resistance to anti-angiogenic therapy

Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · see citing works

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Soker, S., Takashima, S., Miao, H., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,634 · see citing works

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

Pàez‐Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,344 · see citing works

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

Mendel, D. B., Laird, A., Xin, X., Louie, S. G., Christensen, J. G., Li, G., Schreck, R., Abrams, T. J., Ngai, T. J., Lee, L. B., et al. (2003) · PubMed · Cited by 1,968 · see citing works

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

Ebos, J. M. L., Lee, C. R., Cruz‐Muñoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,710 · see citing works

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., Mol, M. D., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,673 · see citing works

Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5

Liu, L., Cao, Y., Chen, C., Zhang, X., McNabola, A., Wilkie, D. P., Wilhelm, S. M., Lynch, M. J., & Carter, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1377 · Cited by 1,539 · see citing works

Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1

Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,437 · see citing works

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

Karkkainen, M. J., Haiko, P., Sainio, K., Partanen, J. M., Taipale, J., Petrova, T. V., Jeltsch, M., Jackson, D. G., Talikka, M., Rauvala, H., et al. (2003) · Nature Immunology · doi:10.1038/ni1013 · Cited by 1,419 · see citing works

Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice

Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M. A., Fukumura, D., Jain, R. K., & Alitalo, K. K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,279 · see citing works

Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor

Appelhoff, R. J., Tian, Y.-M., Raval, R. R., Turley, H., Harris, A. L., Pugh, C. W., Ratcliffe, P. J., & Gleadle, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406026200 · Cited by 1,108 · see citing works

Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response

Dewhirst, M. W., Cao, Y., & Moeller, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2397 · Cited by 1,022 · see citing works

Molecular targeted therapies in hepatocellular carcinoma†

Llovet, J. M., & Bruix, J. (2008) · Hepatology · doi:10.1002/hep.22506 · Cited by 999 · see citing works

Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization

Mazzone, M., Dettori, D., de Oliveira, R. L., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A. A., Pollard, P. J., de Almodóvar, C. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.020 · Cited by 803 · see citing works

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

Autiero, M., Waltenberger, J. L., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Krøll, J., Plaisance, S., Mol, M. D., Bono, F., et al. (2003) · Nature Medicine · doi:10.1038/nm884 · Cited by 775 · see citing works

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

Kamba, T., Tam, B. Y. Y., Hashizume, H., Haskell, A., Sennino, B., Mancuso, M. R., Norberg, S. M., O’Brien, S., Davis, R. B., Gowen, L. C., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00133.2005 · Cited by 773 · see citing works

Hypoxia and cancer

Brahimi-Horn, M. C., Chiche, J., & Pouysségur, J. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0281-3 · Cited by 765 · see citing works

Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma

Villanueva, A., Chiang, D. Y., Newell, P., Peix, J., Thung, S. N., Alsinet, C., Tovar, V., Roayaie, S., Mínguez, B., Solé, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.008 · Cited by 734 · see citing works

AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer

Wedge, S. R., Kendrew, J., Hennequin, L. F., Valentine, P. J., Barry, S. T., Brave, S. R., Smith, N. R., James, N. H., Dukes, M., Curwen, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4409 · Cited by 720 · see citing works

The codependence of angiogenesis and chronic inflammation

Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., & Winkler, J. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194526 · Cited by 690 · see citing works

CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells

Dawson, D. W., Pearce, S. F. A., Zhong, R., Silverstein, R. L., Frazier, W. A., & Bouck, N. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.3.707 · Cited by 676 · see citing works

A novel endothelial-specific membrane protein is a marker of cell-cell contacts.

Lampugnani, M. G., Resnati, M., Raiteri, M., Pigott, R., Pisacane, A., Houen, G., Ruco, L., & Dejana, E. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.118.6.1511 · Cited by 632 · see citing works

Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

Reynolds, L. E., Wyder, L., Lively, J. C., Taverna, D., Robinson, S. D., Huang, X., Sheppard, D., Hynes, R. O., & Hodivala‐Dilke, K. (2002) · Nature Medicine · doi:10.1038/nm0102-27 · Cited by 614 · see citing works

Endostatin Induces Endothelial Cell Apoptosis

Dhanabal, M., Ramchandran, R., Waterman, M. J. F., Lu, H. A. J., Knebelmann, B., Segal, M. S., & Sukhatme, V. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11721 · Cited by 582 · see citing works

Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor

Ivan, M., Haberberger, T., Gervasi, D. C., Michelson, K. S., Günzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R. C., Conaway, J. W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192342099 · Cited by 561 · see citing works

Role of MAP kinase in tumor progression and invasion

Reddy, K. B., Nabha, S. M., & Atanaskova, N. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023781114568 · Cited by 511 · see citing works

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

Siegel, A. B., Cohen, E. I., Ocean, A. J., Lehrer, D., Goldenberg, A. S., Knox, J. J., Chen, H., Clark-Garvey, S., Weinberg, A. D., Mandeli, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9947 · Cited by 505 · see citing works

Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications

Friedman, S. L. (2004) · Nature Clinical Practice Gastroenterology &#38 Hepatology · doi:10.1038/ncpgasthep0055 · Cited by 499 · see citing works

Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

Zhu, A. X., Sahani, D. V., Duda, D. G., di Tomaso, E., Ancukiewicz, M., Catalano, O. A., Sindhwani, V., Blaszkowsky, L. S., Yoon, S. S., Lahdenranta, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9908 · Cited by 477 · see citing works

Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer

Philip, P. A., Mahoney, M. R., Allmer, C., Thomas, J. P., Pitot, H. C., Kim, G., Donehower, R. C., Fitch, T. R., Picus, J., & Erlichman, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.696 · Cited by 462 · see citing works

Expression of vascular endothelial growth factor in human hepatocellular carcinoma

Yamaguchi, R., Yano, H., Iemura, A., Ogasawara, S., Haramaki, M., & Kojiro, M. (1998) · Hepatology · doi:10.1002/hep.510280111 · Cited by 397 · see citing works

Signal transduction by β-catenin

Gumbiner, B. M. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80104-9 · Cited by 394 · see citing works

Phase II Study of Gemcitabine and Oxaliplatin in Combination With Bevacizumab in Patients With Advanced Hepatocellular Carcinoma

Zhu, A. X., Blaszkowsky, L. S., Ryan, D. P., Clark, J. W., Muzikansky, A., Horgan, K. E., Sheehan, S., Hale, K., Enzinger, P. C., Bhargava, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.9130 · Cited by 388 · see citing works

mTOR and P70 S6 Kinase Expression in Primary Liver Neoplasms

Sahin, F., Kannangai, R., Adegbola, O., Wang, J., Su, G. H., & Torbenson, M. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0941 · Cited by 382 · see citing works

Biological consequences of tumor hypoxia

ckel, M. H., & Vaupel, P. W. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90211-8 · Cited by 381 · see citing works

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

Ebos, J. M. L., Lee, C. R., Christensen, J. G., Mutsaers, A. J., & Kerbel, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708148104 · Cited by 368 · see citing works

Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD

Claesson, L., Welsh, M., Ito, N., Anand‐Apte, B., Söker, S., Zetter, B. R., O’Reilly, M. S., & Folkman, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5579 · Cited by 345 · see citing works

Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells†

Aleffi, S., Petrai, I., Bertolani, C., Parola, M., Colombatto, S., Novo, E., Vizzutti, F., Anania, F. A., Milani, S., Rombouts, K., et al. (2005) · Hepatology · doi:10.1002/hep.20965 · Cited by 342 · see citing works

Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis†

Schiffer, E. R. C., Housset, C., Cacheux, W., Wendum, D., Desbois‐Mouthon, C., Rey, C., Clergue, F., Poupon, R. Y., Barbu, V. D., & Rosmorduc, O. (2005) · Hepatology · doi:10.1002/hep.20538 · Cited by 338 · see citing works

Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma

Thomas, M. B., Morris, J. S., Chadha, R., Iwasaki, M., Kaur, H., Lin, E., Kaseb, A. O., Glover, K. Y., Davila, M. L., & Abbruzzese, J. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.3301 · Cited by 334 · see citing works

Mice Lacking the Vascular Endothelial Growth Factor-B Gene ( Vegfb ) Have Smaller Hearts, Dysfunctional Coronary Vasculature, and Impaired Recovery From Cardiac Ischemia

Bellomo, D., Headrick, J. P., Silins, G. U., Paterson, C. A., Thomas, P. S., Gartside, M. G., Mould, A. W., Cahill, M. M., Tonks, I. D., Grimmond, S. M., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.2.e29 · Cited by 333 · see citing works

Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)

Bellentani, S., & Marino, M. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31820-4 · Cited by 322 · see citing works

Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins

Kevil, C. G., Payne, D. K., Mire, E., & Alexander, J. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15099 · Cited by 320 · see citing works

Pathophysiology of nonalcoholic steatohepatitis.

McCullough, A. J. (2006) · PubMed · doi:10.1097/01.mcg.0000168645.86658.22 · Cited by 317 · see citing works

PATHOPHYSIOLOGY OF PORTAL HYPERTENSION

Bosch, J., Pizcueta, P. M., Feu, F., Fernández, M., & García‐Pagán, J. C. (1992) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00175-8 · Cited by 314 · see citing works

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Hicklin, D. J., Wu, Y., Yanase, K., Namisaki, T., Yamazaki, M., et al. (2003) · Gut · doi:10.1136/gut.52.9.1347 · Cited by 307 · see citing works

Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma

Thomas, M. B., Chadha, R., Glover, K. Y., Wang, X., Morris, J. S., Brown, T. D., Rashid, A., Dancey, J. E., & Abbruzzese, J. L. (2007) · Cancer · doi:10.1002/cncr.22886 · Cited by 305 · see citing works

Integrins and Angiogenesis

Stupack, D. G., & Cheresh, D. A. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)64009-9 · Cited by 297 · see citing works

Pathophysiology of Nonalcoholic Steatohepatitis

Başaranoğlu, M. (2009) · Cited by 294 · see citing works

Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy

Ebos, J. M. L., Lee, C. R., & Kerbel, R. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0095 · Cited by 291 · see citing works

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

Faivre, S. J., Raymond, É., Boucher, É., Douillard, J.-Y., Lim, H. Y., Kim, J. S., Zappa, M., Lanzalone, S., Lin, X., DePrimo, S. E., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70171-8 · Cited by 290 · see citing works

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

Ramanathan, R. K., Belani, C. P., Singh, D. A., Tanaka, M. S., Lenz, H., Yen, Y., Kindler, H. L., Iqbal, S., Longmate, J., Mack, P. C., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-0927-7 · Cited by 284 · see citing works

Identification of a new fibroblast growth factor receptor, FGFR5.

Sleeman, M. A., Fraser, J. W., McDonald, M., Yuan, S.-N., White, D., Grandison, P., Kumble, K. D., Watson, J. D., & Murison, J. (2001) · Gene · doi:10.1016/s0378-1119(01)00518-2 · Cited by 284 · see citing works

Platelet-Derived Growth Factor is Angiogenic In Vivo

Risau, W., Drexler, H. C. A., Mironov, V., Smits, A., Siegbahn, A., Funa, K., & Heldin, C. (1992) · Growth Factors · doi:10.3109/08977199209046408 · Cited by 283 · see citing works

PDGF and Vessel Maturation

Hellberg, C. B., Östman, A., & Heldin, C. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-78281-0_7 · Cited by 264 · see citing works

Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis

Cusi, K. J. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.009 · Cited by 263 · see citing works

Increased Expression of Vascular Endothelial Growth Factor and Angiogenesis in the Early Stage of Multistep Hepatocarcinogenesis

Park, Y. N., Kim, Y., Yang, K. M., & Park, C. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-1061-ieoveg · Cited by 261 · see citing works

Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats

Tugues, S., Fernández‐Varo, G., Muñoz, J., Ros, J., Arroyo, V., Rodés, J., Friedman, S. L., Carmeliet, P., Jiménez, W., & Morales‐Ruiz, M. (2007) · Hepatology · doi:10.1002/hep.21921 · Cited by 260 · see citing works

Pathophysiology of Nonalcoholic Steatohepatitis

Watanabe, S. (2017) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.63.230 · Cited by 257 · see citing works

Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease

de Veire, S. V., Stalmans, I., Heindryckx, F., Oura, H., Tijeras‐Raballand, A., Schmidt, T., Loges, S., Albrecht, I., Jonckx, B., Vinckier, S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.039 · Cited by 255 · see citing works

Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

Zhu, A. X., Stuart, K. E., Blaszkowsky, L. S., Muzikansky, A., Reitberg, D. P., Clark, J. W., Enzinger, P. C., Bhargava, P., Meyerhardt, J. A., Horgan, K. E., et al. (2007) · Cancer · doi:10.1002/cncr.22829 · Cited by 245 · see citing works

Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes

Safadi, R., Ohta, M., Alvarez, C. E., Fiel, M. I., Bansal, M., Mehal, W. Z., & Friedman, S. L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.062 · Cited by 239 · see citing works

Pathogenesis of nonalcoholic steatohepatitis

Liu, W., Baker, R. D., Bhatia, T., Zhu, L., & Baker, S. S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2161-x · Cited by 225 · see citing works

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo

Newell, P., Toffanin, S., Villanueva, A., Chiang, D. Y., Mínguez, B., Cabellos, L., Savić, R., Hoshida, Y., Lim, K. H., Melgar‐Lesmes, P., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.028 · Cited by 222 · see citing works

Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma

Huynh, H. T., Ngo, V. C., Fargnoli, J., Ayers, M., Soo, K. C., Koong, H. N., Thng, C. H., Ong, H. S., Chung, A. Y. F., Chow, P. K. H., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0509 · Cited by 221 · see citing works

Proangiogenic Cytokines as Hypoxia-Dependent Factors Stimulating Migration of Human Hepatic Stellate Cells

Novo, E., Cannito, S., Zamara, E., di Bonzo, L. V., Caligiuri, A., Cravanzola, C., Compagnone, A., Colombatto, S., Marra, F., Pinzani, M., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060887 · Cited by 220 · see citing works

Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats

Fernández, M., Mejías, M., Angermayr, B., García‐Pagán, J. C., Rodés, J., & Bosch, J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.022 · Cited by 217 · see citing works

Normal Development, Wound Healing, and Adenovirus Susceptibility in β5-Deficient Mice

Huang, X., Griffiths, M., Wu, J., Farese, R. V., & Sheppard, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.755-759.2000 · Cited by 215 · see citing works

Chemokines in liver inflammation and fibrosis

Marra, F. (2002) · Frontiers in bioscience · doi:10.2741/a887 · Cited by 214 · see citing works

Molecular Cloning, Expression, and Characterization of Angiopoietin-related Protein

Kim, I., Moon, S.-O., Koh, K. N., Kim, H., Uhm, C.-S., Kwak, H. J., Kim, N.-G., & Koh, G. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26523 · Cited by 212 · see citing works

Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice

McCuskey, R. S., Ito, Y., Robertson, G. R., McCuskey, M. K., Perry, M. A., & Farrell, G. C. (2004) · Hepatology · doi:10.1002/hep.20302 · Cited by 211 · see citing works

Prognostic Significance of Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Angiogenin in Patients With Resectable Hepatocellular Carcinoma After Surgery

Chao, Y., Li, C., Chau, G., Chen, C., King, K., Lui, W., Yen, S., Chang, F., Chan, W., & Lee, S. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.10.002 · Cited by 209 · see citing works

Integrins and angiogenesis: A sticky business

Serini, G., Valdembri, D., & Bussolino, F. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.020 · Cited by 207 · see citing works

Deletion of Vascular Endothelial Growth Factor C (VEGF-C) and VEGF-D Is Not Equivalent to VEGF Receptor 3 Deletion in Mouse Embryos

Haiko, P., Mäkinen, T., Keskitalo, S., Taipale, J., Karkkainen, M. J., Baldwin, M. E., Stacker, S. A., Achen, M. G., & Alitalo, K. K. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02214-07 · Cited by 199 · see citing works

A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of c-Met and Vascular Endothelial Growth Factor Receptor 2

Eder, J. P., Shapiro, G. I., Appleman, L. J., Zhu, A. X., Miles, D., Keer, H. N., Cancilla, B., Chu, F., Hitchcock‐Bryan, S., Sherman, L. J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0574 · Cited by 198 · see citing works

Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC)

Louafi, S., Boige, V., Ducreux, M. P., Bonyhay, L., Mansourbakht, T., de Baère, T., Asnacios, A., Hannoun, L., Poynard, T., & Taı̈eb, J. (2007) · Cancer · doi:10.1002/cncr.22532 · Cited by 196 · see citing works

Pathogenesis of Non-alcoholic Steatohepatitis: Human Data

Edmison, J. M., & McCullough, A. J. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.011 · Cited by 193 · see citing works

Thrombospondin‐1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor‐related protein‐1 (LRP‐1)

Greenaway, J. B., Lawler, J., Moorehead, R. A., BORNSTEIN, P. K., LaMarre, J., & Petrik, J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20904 · Cited by 187 · see citing works

Angiogenesis and inflammation face off

Imhof, B. A., & Aurrand‐Lions, M. (2006) · Nature Medicine · doi:10.1038/nm0206-171 · Cited by 181 · see citing works

Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells

Ankoma‐Sey, V., Wang, Y., & Dai, Z. (2000) · Hepatology · doi:10.1002/hep.510310122 · Cited by 179 · see citing works

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats

Fernández, M., Mejías, M., García‐Pras, E., Méndez, R., García‐Pagán, J. C., & Bosch, J. (2007) · Hepatology · doi:10.1002/hep.21785 · Cited by 177 · see citing works

VE-Cadherin-Mediated Cell-Cell Interaction Suppresses Sprouting via Signaling to MLC2 Phosphorylation

Abraham, S., Yeo, M., Montero‐Balaguer, M., Paterson, H., Dejana, E., Marshall, C. J., & Mavria, G. (2009) · Current Biology · doi:10.1016/j.cub.2009.02.057 · Cited by 163 · see citing works

Microvessel Density, Vascular Endothelial Growth Factor and Its Receptors Flt-1 and Flk-1/KDR in Hepatocellular Carcinoma

Ng, I. O., Poon, R. T. P., Lee, J. M. F., Fan, S. T., NG, M. M., & Tso, W. K. (2001) · American Journal of Clinical Pathology · doi:10.1309/fxnl-qtn1-94fh-ab3a · Cited by 162 · see citing works

Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells.

Sachinidis, A., Locher, R., Vetter, W., Tatje, D., & Hoppe, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86937-x · Cited by 154 · see citing works

Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial

Rimassa, L., & Santoro, A. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.41 · Cited by 153 · see citing works

Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis.

Marx, M., Perlmutter, R. A., & Madri, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116936 · Cited by 152 · see citing works

Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma

Huynh, H. T., Soo, K. C., Chow, P. K. H., & Tran, E. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0436 · Cited by 150 · see citing works

Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival

Huang, G. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i11.1705 · Cited by 149 · see citing works

Leptin‐mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats†

Kitade, M., Yoshiji, H., Kojima, H., Ikenaka, Y., Noguchi, R., Kaji, K., Yoshii, J., Yanase, K., Namisaki, T., Asada, K., et al. (2006) · Hepatology · doi:10.1002/hep.21338 · Cited by 145 · see citing works

ET-1 induced alterations of hepatic microcirculation: sinusoidal and extrasinusoidal sites of action

Bauer, M. W., Zhang, J. X., Bauer, I., & Clemens, M. G. (1994) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1994.267.1.g143 · Cited by 140 · see citing works

Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen‐induced and collagen‐induced models of arthritis

Mould, A. W., Tonks, I. D., Cahill, M. M., Pettit, A. R., Thomas, R., Hayward, N. K., & Kay, G. F. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11232 · Cited by 136 · see citing works

Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer

Rizell, M., Andersson, M., Cahlin, C., Hafström, L., Olausson, M., & Lindnér, P. (2008) · International Journal of Clinical Oncology · doi:10.1007/s10147-007-0733-3 · Cited by 134 · see citing works

Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma

Hsu, C., Yang, T.-S., Hsu, C., Toh, H. C., Epstein, R. J., Hsiao, L.-T., Chen, P.-J., Lin, Z.-Z., Chao, T.-Y., & Cheng, A.-L. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605580 · Cited by 132 · see citing works

Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

Huynh, H. T., Ngo, V. C., Koong, H. N., Poon, D. Y. H., Choo, S. P., Thng, C. H., Chow, P. K. H., Ong, H. S., Chung, A. Y. F., & Soo, K. C. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00692.x · Cited by 130 · see citing works

Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin‐2 and hypoxia‐induced factor‐1a

Wada, H., Nagano, H., Yamamoto, H., Yang, Y., Kondo, M., Ota, H., Nakamura, M., Yoshioka, S., Kato, H., Damdinsuren, B., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01243.x · Cited by 130 · see citing works

Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.

Yao, D., Wu, X., Zhu, Y. M., Shi, G.-S., Dong, Z., Yao, D.-B., Wu, W., Qiu, L., & Meng, X. (2005) · PubMed · Cited by 128 · see citing works

Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro

Bootle-Wilbraham, C. A., Tazzyman, S. J., Thompson, W. D., Stirk, C. M., & Lewis, C. E. (2001) · Angiogenesis · doi:10.1023/a:1016076121918 · Cited by 126 · see citing works

Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver

Zhang, J. X., Bauer, M. W., & Clemens, M. G. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.269.2.g269 · Cited by 123 · see citing works

High Serum Vascular Endothelial Growth Factor Levels Predict Poor Prognosis after Radiofrequency Ablation of Hepatocellular Carcinoma: Importance of Tumor Biomarker in Ablative Therapies

Poon, R. T. P., Lau, C. P.-Y., Pang, R. W. C., Ng, K. K., Yuen, J. H. F., & Fan, S. T. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9366-z · Cited by 117 · see citing works

Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism.

Camussi, G., Montrucchio, G. G., Lupia, E., Martino, A. D., Perona, L., Arese, M., Vercellone, A., Toniolo, A., & Bussolino, F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.12.6492 · Cited by 107 · see citing works

SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity

Patyna, S. J., Laird, A., Mendel, D. B., O’Farrell, A.-M., Liang, C., Guan, H., Vojkovský, T., Vasile, S., Wang, X., Chen, J. W., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0333 · Cited by 105 · see citing works

Fat distribution and storage: how much, where, and how?

Weiss, R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0125 · Cited by 102 · see citing works

Prognostic Factors and Recurrence of Small Hepatocellular Carcinoma after Hepatic Resection or Microwave Ablation: A Retrospective Study

Wang, Z., Liang, P., Dong, B., Yu, X., & Yu, D. J. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0310-0 · Cited by 100 · see citing works

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

Huynh, H. T., Ngo, V. C., Koong, H. N., Poon, D. Y. H., Choo, S. P., Toh, H. C., Thng, C. H., Chow, P. K. H., Ong, H. S., Chung, A. Y. F., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.008 · Cited by 99 · see citing works

The biology of vascular endothelial growth factor-B (VEGF-B)

Nash, A. D., Baca, M., Wright, C. E., & Scotney, P. D. (2005) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2005.02.007 · Cited by 97 · see citing works

Multidrug resistance gene (MDR‐1) expression as a useful prognostic factor in patients with human hepatocellular carcinoma after surgical resection

Kato, A., Miyazaki, M., Ambiru, S., Yoshitomi, H., Ito, H., Nakagawa, K., Shimizu, H., Yokosuka, O., & Nakajima, N. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1129 · Cited by 97 · see citing works

Pathophysiology of portal hypertension.

Cichoz-Lach, H., Celiński, K., Słomka, M., & Kasztelan‐Szczerbińska, B. (2008) · PubMed · Cited by 97 · see citing works

Phosphatidylinositol 3′-Kinase-independent p70 S6 Kinase Activation by Fibroblast Growth Factor Receptor-1 Is Important for Proliferation but Not Differentiation of Endothelial Cells

Kanda, S., Hodgkin, M. N., Woodfield, R. J., Wakelam, M. J. O., Thomas, G., & Claesson, L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23347 · Cited by 93 · see citing works

Continuous Sunitinib Treatment in Patients with Advanced Hepatocellular Carcinoma: A Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) Multicenter Phase II Trial (SAKK 77/06)

Koeberle, D., Montemurro, M., Samaras, P., Majno, P. E., Simcock, M., Limacher, A., Lerch, S., Kovács, K. J., Inauen, R. I., Hess, V., et al. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0316 · Cited by 92 · see citing works

The management of alcoholic liver disease

Stewart, S. F., & Day, C. P. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00427-0 · Cited by 91 · see citing works

Angiostatin Diminishes Activation of the Mitogen-Activated Protein Kinases ERK-1 and ERK-2 in Human Dermal Microvascular Endothelial Cells

Redlitz, A., Daum, G., & Sage, E. H. (1999) · Journal of Vascular Research · doi:10.1159/000025623 · Cited by 88 · see citing works

Low-Dose Thalidomide Treatment for Advanced Hepatocellular Carcinoma

Hsu, C., Chen, C., Chen, L., Wu, C., Yang, P., Lai, M., Lee, P., & Cheng, A. (2003) · Oncology · doi:10.1159/000074477 · Cited by 87 · see citing works

Fibroblast growth factors as angiogenesis factors: New insights into their mechanism of action

Klein, S. S., Roghani, M., & Rifkin, D. B. (1997) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9006-9_7 · Cited by 87 · see citing works

The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line

Huang, M. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00280-8 · Cited by 84 · see citing works

VEGF‐A, VEGF‐D and VEGF‐DΔNΔC induced intimal hyperplasia in carotid arteries

Bhardwaj, S., Roy, H., Heikura, T., & Ylä‐Herttuala, S. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01555.x · Cited by 79 · see citing works

mTOR inhibitors for hepatocellular cancer: a forward-moving target

Treiber, G. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.9.2.247 · Cited by 76 · see citing works

Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus

Zhou, J., Tang, Z., Fan, J., Wu, Z.-Q., Li, X., Liu, Y., Liu, F., Sun, H., & Ye, S. (2000) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050009 · Cited by 74 · see citing works

Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model

Finn, R. S., Bentley, G. V., Britten, C. D., Amado, R. G., & Busuttil, R. W. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01762.x · Cited by 73 · see citing works

The Potential of Angiogenesis Soluble Markers in Chronic Hepatitis C *

Salcedo-Mora, X., Medina, J., Sanz-Cameno, P., Garcı́a-Buey, L., Martín‐Vílchez, S., Borque, M. J., López‐Cabrera, M., & Moreno‐Otero, R. (2005) · Hepatology · doi:10.1002/hep.20828 · Cited by 73 · see citing works

Inhibition of Hepatic Stellate Cell Proliferation and Activation by the Semisynthetic Analogue of Fumagillin Tnp–470 in Rats

Wang, Y. Q., Ikeda, K., Ikebe, T., Hirakawa, K., Sowa, M., Nakatani, K., Kawada, N., & Kaneda, K. (2000) · Hepatology · doi:10.1053/jhep.2000.18658 · Cited by 73 · see citing works

Role of Kupffer cells in gut ischemia/reperfusion-induced hepatic microvascular dysfunction in mice

Horie, Y., Wolf, R., Russell, J., Shanley, T. P., & Granger, D. N. (1997) · Hepatology · doi:10.1002/hep.510260617 · Cited by 72 · see citing works

Rat liver endothelial cells isolated by anti-CD31 immunomagnetic separation lack fenestrae and sieve plates

DeLeve, L. D., Wang, X., McCuskey, M. K., & McCuskey, R. S. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00229.2006 · Cited by 71 · see citing works

Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study

Geerts, A. M., Vriese, A. S. D., Vanheule, E., Vlierberghe, H. V., Mortier, S., Cheung, K., Demetter, P., Lameire, N. H., Vos, M. D., & Colle, I. O. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01308.x · Cited by 71 · see citing works

III. Leukocyte adhesion and transmigration in the liver vasculature*

Jaeschke, H., & Smith, C. W. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.6.g1169 · Cited by 71 · see citing works

Expression of the platelet‐derived growth factor β receptor during organogenesis and tissue differentiation in the mouse embryo

Shinbrot, E., Peters, K. G., & Williams, L. T. (1994) · Developmental Dynamics · doi:10.1002/aja.1001990302 · Cited by 70 · see citing works

Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma

Ho, M., Chen, C., Lee, H., Hsieh, F., Shun, C., Chang, C., Lai, Y.-T., & Lee, P. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.10.005 · Cited by 69 · see citing works

Modulation of Angiogenesis in Vitro by Laminin-Entactin Complex

Nicosia, R. F., Bonanno, E., Smith, M., & Yurchenco, P. D. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1191 · Cited by 68 · see citing works

Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico‐pathological parameters

Kanda, M., Nomoto, S., Nishikawa, Y., Sugimoto, H., Kanazumi, N., Takeda, S., & Nakao, A. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21095 · Cited by 68 · see citing works

Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles

Simpson, K. J., Henderson, N. C., Bone‐Larson, C. L., Lukacs, N. W., Hogaboam, C. M., & Kunkel, S. L. (2003) · Clinical Science · doi:10.1042/cs20020137 · Cited by 68 · see citing works

Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1α inhibition

Du, G., Han, G., Zhang, S., Lin, H., Wu, X., Wang, M., Ji, L., Lu, L., Yu, L., & Liang, W. P. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.014 · Cited by 67 · see citing works

Hepatocellular Carcinoma

Maïo, M. D., Maio, E. D., Perrone, F., Pignata, S., & Daniele, B. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200211002-00007 · Cited by 65 · see citing works

Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: A prospective study

Jeng, K. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i5.643 · Cited by 64 · see citing works

Inflammation: a way to understanding the evolution of portal hypertension

Aller, M., Arias, J.-L., Cruz, A., & Árias, J. (2007) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-4-44 · Cited by 63 · see citing works

Mast cells and angiogenesis

Levi‐Schaffer, F., & Pe'er, J. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01041.x · Cited by 62 · see citing works

Detection of characteristic sub pathway network for angiogenesis based on the comprehensive pathway network

Huang, Y., & Li, S. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-s1-s32 · Cited by 61 · see citing works

Role of Placental Growth Factor in Mesenteric Neoangiogenesis in a Mouse Model of Portal Hypertension

Steenkiste, C. V., Geerts, A. M., Vanheule, E., Vlierberghe, H. V., Vos, F. D., Olievier, K., Casteleyn, C. R., Laukens, D., Vos, M. D., Stassen, J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.068 · Cited by 61 · see citing works

Blockade of renin–angiotensin system in antifibrotic therapy

Yoshiji, H., Kuriyama, S., & Fukui, H. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04663.x · Cited by 60 · see citing works

NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats

Angermayr, B., Fernández, M., Mejías, M., Gracia‐Sancho, J., García‐Pagán, J. C., & Bosch, J. (2006) · Gut · doi:10.1136/gut.2005.088013 · Cited by 60 · see citing works

Hepatocyte growth factor, vascular endothelial growth factor, glial cell-derived neurotrophic factor and nerve growth factor are differentially affected by early chronic ethanol or red wine intake

Fiore, M., Mancinelli, R., Aloe, L., Giovanni Laviola, A., Sornelli, F., Vitali, M., & Ceccanti, M. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.04.013 · Cited by 54 · see citing works

Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection

Cui, J. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i10.1533 · Cited by 53 · see citing works

Platelet-derived growth factor receptors on macrovascular endothelial cells mediate relaxation via nitric oxide in rat aorta.

Cunningham, L., Brecher, P. I., & Cohen, R. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115667 · Cited by 51 · see citing works

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma

Iavarone, M. A., Lampertico, P., Iannuzzi, F., Manenti, E., Donato, M. F., Arosio, E., Bertolini, F., Primignani, M., Sangiovanni, A., & Colombo, M. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00782.x · Cited by 50 · see citing works

Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines

Morelli, M. P., Brown, A. M., Pitts, T. M., Tentler, J. J., Ciardiello, F., Ryan, A. J., Jürgensmeier, J. M., & Eckhardt, S. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0380 · Cited by 50 · see citing works

Transcriptional regulation of stellate cell activation

Friedman, S. L. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04585.x · Cited by 47 · see citing works

Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status

Wang‐Rodriguez, J., Urquidi, V., Rivard, A. L., & Steve Goodison, B. (2003) · Breast Cancer Research · doi:10.1186/bcr620 · Cited by 47 · see citing works

Correlation of VEGF production with IL1α and IL6 secretion by human pituitary adenoma cells

Borg, S. A., Kerry, K., Royds, J. A., Battersby, R. D. E., & Jones, T. H. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01843 · Cited by 45 · see citing works

Transcriptional Regulation in Hepatic Stellate Cells

Eng, F. J., & Friedman, S. L. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17553 · Cited by 44 · see citing works

The Complex Functions of Mast Cells in Chronic Human Liver Diseases

Franceschini, B., Ceva‐Grimaldi, G., Russo, C., Dioguardi, N., & Grizzi, F. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9082-8 · Cited by 44 · see citing works

Development of Sunitinib in Hepatocellular Carcinoma: Rationale, Early Clinical Experience, and Correlative Studies

Zhu, A. X., Duda, D. G., Sahani, D. V., & Jain, R. K. (2009) · The Cancer Journal · doi:10.1097/ppo.0b013e3181af5e35 · Cited by 43 · see citing works

Crosstalk between angiogenesis, cytokeratin-18, and insulinresistance in the progression of non-alcoholic steatohepatitis

Kitade, M., Yoshiji, H., Noguchi, R., Ikenaka, Y., Kaji, K., Shirai, Y., Yamazaki, M., Uemura, M., Yamao, J., Fujimoto, M., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5193 · Cited by 43 · see citing works

Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.

Zhao, J., Hu, J., Cai, J., Yang, X., & Yang, Z. (2003) · PubMed · Cited by 43 · see citing works

Detection of Hypoxia Inducible Factors and Angiogenic Growth Factors during Foetal Endochondral and Intramembranous Ossification

Spiegelaere, W. D., Cornillie, P., Casteleyn, C. R., Burvenich, C., & Broeck, W. V. D. (2010) · Anatomia Histologia Embryologia · doi:10.1111/j.1439-0264.2010.01005.x · Cited by 41 · see citing works

Antiangiogenic therapy: Not just for cancer anymore? # †

Shah, V. H., & Bruix, J. (2009) · Hepatology · doi:10.1002/hep.22872 · Cited by 38 · see citing works

Hepatic Artery Flow and Propranolol Metabolism in Perfused Cirrhotic Rat Liver

Couteur, D. G. L., Hickey, H. M., Harvey, P. J., Gready, J. E., & McLean, A. J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38305-3 · Cited by 36 · see citing works

Regulation der Endothelfunktion und der Angiogenese durch den Vaskulären Endothelialen Wachstumsfaktor-A (VEGF-A)

Krøll, J., & Waltenberger, J. L. (2000) · Zeitschrift für Kardiologie · doi:10.1007/s003920050472 · Cited by 34 · see citing works

Thalidomide in Advanced Hepatocellular Carcinoma with Optional Low-Dose Interferon-α2a upon Progression

Schwartz, J. D., Sung, M. W., Schwartz, M., Lehrer, D., Mandeli, J., Liebes, L., Goldenberg, A. S., & Volm, M. D. (2005) · The Oncologist · doi:10.1634/theoncologist.10-9-718 · Cited by 34 · see citing works

Review article: angiogenesis soluble factors as liver disease markers

Salcedo-Mora, X., Medina, J., Sanz-Cameno, P., Garcı́a-Buey, L., Martín‐Vílchez, S., & Moreno‐Otero, R. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02532.x · Cited by 33 · see citing works

ZD6474 inhibits proliferation and invasion of human hepatocellular carcinoma cells

Giannelli, G., Azzariti, A., Sgarra, C., Porcelli, L., Antonaci, S., & Paradiso, A. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.005 · Cited by 31 · see citing works

Expresión génica en pacientes obesos con enfermedad hepática por depósito de grasa

Cayon, A., Crespo, J., Guerra, A. R., & Pons‐Romero, F. (2008) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082008000400004 · Cited by 29 · see citing works

Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development

Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Yanase, K., Namisaki, T., Kitade, M., Yamazaki, M., Tsujinoue, H., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.001 · Cited by 28 · see citing works

Sinusoidal Capillarization and Arterial Blood Supply Continuously Proceed with the Advance of the Stages of Hepatocarcinogenesis in the Rat

Yamamoto, T., Kaneda, K., Hirohashi, K., Kinoshita, H., & Sakurai, M. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb00244.x · Cited by 26 · see citing works

Relationship of the Microvascular Type to the Tumor Size, Arterialization and Dedifferentiation of Human Hepatocellular Carcinoma

Yamamoto, T., Hirohashi, K., Kaneda, K., Ikebe, T., Mikami, S., Uenishi, T., Kanazawa, A., Takemura, S., Shuto, T., Tanaka, H., et al. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb02141.x · Cited by 25 · see citing works

Inhibition of mTOR suppresses experimental liver tumours.

Rizell, M., & Lindnér, P. (2005) · PubMed · Cited by 25 · see citing works

Effect of Thalidomide in Hepatocellular Carcinoma: Assessment with Power Doppler US and Analysis of Circulating Angiogenic Factors

Hsu, C., Chen, C., Chen, L., Wu, C.-Y., Hsieh, F., & Cheng, A. (2005) · Radiology · doi:10.1148/radiol.2352040271 · Cited by 25 · see citing works

Induction of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9 via CD47 Signaling in Neurovascular Cells

Xing, C., Arai, K., Park, K., & Lo, E. H. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0159-6 · Cited by 22 · see citing works

Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial

Pinter, M., Wichlas, M., Schmid, K., Plank, C. M., Müller, C., Wrba, F., & Peck‐Radosavljevic, M. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283036740 · Cited by 21 · see citing works

Tyrosine kinase inhibitors to treat liver cancer

Huynh, H. T. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210903571659 · Cited by 20 · see citing works

HEPATOCELLULAR CARCINOMA

Gonzalez, K. B., & Woodall, M. L. (2001) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02581-6 · Cited by 19 · see citing works

Rapamycin prevents mesenteric neo‐angiogenesis and reduces splanchnic blood flow in portal hypertensive mice

Geerts, A. M., Vanheule, E., Vlierberghe, H. V., Leybaert, L., Steenkiste, C. V., Vos, M. D., & Colle, I. O. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00369.x · Cited by 16 · see citing works

Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression

Xiong, Y., Sun, H., Zhu, X., Zhang, W., Zhuang, P., Zhang, J., Xu, H., Kong, L., Wu, W., Qin, L., et al. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0914-8 · Cited by 15 · see citing works

Cell density regulates prolyl 4-hydroxylase activity independent of mRNA levels

Lee, E. H., Kao, W. W. ‐., & Schwarz, R. I. (2001) · Matrix Biology · doi:10.1016/s0945-053x(00)00123-2 · Cited by 14 · see citing works

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib

Yau, T. C. C., Pang, R. W. C., Chan, P., & Poon, R. T. P. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003724705 · Cited by 14 · see citing works

Splenic infarction and bevacizumab

Malka, D., den Eynde, M. V., Boige, V., Dromain, C., & Ducreux, M. P. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70980-9 · Cited by 12 · see citing works

Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma

Shiah, H.-S., Chao, Y., Chen, L., Yao, T., Huang, J.-D., Chang, J., Chen, P., Chuang, T.-R., Chin, Y.-H., Whang‐Peng, J., et al. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0203-z · Cited by 12 · see citing works

Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib

Wich, C. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i28.3592 · Cited by 9 · see citing works

Letter to the Editor

Ferrero, S., & Ragni, N. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.08.924 · Cited by 8 · see citing works

Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib

CHRISTINA, C., Wich, Abbas, Agaimy, Deike, Strobel, Thaddaus, WissniowskiArndt, Hartmann, C., Matthias, G., et al. (2010) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 5 · see citing works

Gefitinib Trial in a Fanconi's Anemia Patient with Multiple Squamous Cell Carcinomas and Hepatocellular Carcinoma

Jung, H. S., Byun, G.-W., Lee, K.-E., Mun, Y., Nam, S. H., Kwon, J. M., Lee, S. N., Im, S., Seong, C., & Lee, S. N. (2005) · Cancer Research and Treatment · doi:10.4143/crt.2005.37.6.370 · Cited by 5 · see citing works

Thalidomide for Treating Metastatic Hepatocellular Carcinoma: A Pilot Study

Han, S. H., Park, S. H., Kim, J. H., Lee, J. J., Kwon, S. Y., Kwon, O. S., Kim, S. S., Kim, J. H., Kim, K. K., Park, Y. H., et al. (2006) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2006.21.4.225 · Cited by 5 · see citing works

[Innovative use of the vascular endothelial growth factor in an experimental model of acute liver failure].

Marino, G., Piazzese, E., Gruttadauria, S., Nicotra, G. C., Guarnaccia, M., Emmanuele, G., Francesco, E. D., Travali, S., Bartoloni, G., Messina, A. A., et al. (2004) · PubMed · Cited by 5 · see citing works

Pyruvate-induced Long-term Maintenance of Glutathione S-Transferase in Rat Hepatocyte Cultures

Vanhaecke, T., Foriers, A., Geerts, A. E., Shephard, E. A., Vercruysse, A., & Rogiers, V. (2001) · Alternatives to Laboratory Animals · doi:10.1177/026119290102900324 · Cited by 4 · see citing works

Low dose of thalidomide can be effective in advanced hepatocellular carcinoma

Chen, S., Tsai, H., Jan, C., Wang, Y., & Chen, L. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04303.x · Cited by 3 · see citing works

Gefitinib as an effective therapy for advanced hepatocellular carcinoma with lung metastasis?

Chen, W.-C., Chen, W., Tseng, G.-C., Lai, H.-C., Shih, C., & Hsia, T. C. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02239.x · Cited by 2 · see citing works

Antiangiogenic therapy

Avitabile, T. (2010) · BMC Geriatrics · doi:10.1186/1471-2318-10-s1-l4 · Cited by 1 · see citing works

Hypoalbuminemia: Pathogenesis and Clinical Significance

Soeters, P. B., Wolfe, R. R., & Shenkin, A. (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1451 · Cited by 1,448 · see citing works

Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma

Hernández–Gea, V., Toffanin, S., Friedman, S. L., & Llovet, J. M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.002 · Cited by 718 · see citing works

Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease

Hammoutene, A., & Rautou, P.-E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.012 · Cited by 364 · see citing works

Vascular pathobiology in chronic liver disease and cirrhosis – Current status and future directions

Iwakiri, Y., Shah, V. H., & Rockey, D. C. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.047 · Cited by 312 · see citing works

Hepatic microcirculation and mechanisms of portal hypertension

Gracia‐Sancho, J., Marrone, G., & Fernández‐Iglesias, A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0097-3 · Cited by 288 · see citing works

CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis

Ehling, J., Bartneck, M., Wei, X., Gremse, F., Fech, V., Möckel, D., Baeck, C., Hittatiya, K., Eulberg, D., Luedde, T., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306294 · Cited by 273 · see citing works

Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma

Chen, J., Jin, R., Zhao, J., Liu, J., Ying, H., Yan, H., Zhou, S., Liang, Y., Huang, D., Liang, X. H., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.019 · Cited by 253 · see citing works

The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry

Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 234 · see citing works

Lipid-Induced Toxicity Stimulates Hepatocytes to Release Angiogenic Microparticles That Require Vanin-1 for Uptake by Endothelial Cells

Povero, D., Eguchi, A., Niesman, I. R., Andronikou, N., du Jeu, X. D. M., Mulya, A., Berk, M. P., Lazić, M., Thapaliya, S., Parola, M., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004512 · Cited by 207 · see citing works

Pathological angiogenesis and inflammation in tissues

Jeong, J.-H., Ojha, U., & Lee, Y. M. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01287-2 · Cited by 177 · see citing works

Angiogenesis and liver fibrosis

Elpek, G. Ö. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.377 · Cited by 157 · see citing works

Angiogenesis and Fibrogenesis in Chronic Liver Diseases

Bocca, C., Novo, E., Miglietta, A., & Parola, M. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.06.011 · Cited by 153 · see citing works

Hypoxia-inducible factors as molecular targets for liver diseases

Ju, C., Colgan, S. P., & Eltzschig, H. K. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1408-1 · Cited by 149 · see citing works

The Endothelium as a Driver of Liver Fibrosis and Regeneration

Lafoz, E., Ruart, M., Anton, A., Oncins, A., & Hernández–Gea, V. (2020) · Cells · doi:10.3390/cells9040929 · Cited by 147 · see citing works

TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis

Matsubara, T., Kanto, T., Kuroda, S., Yoshio, S., Higashitani, K., Kakita, N., Miyazaki, M., Sakakibara, M., Hiramatsu, N., Kasahara, A., et al. (2012) · Hepatology · doi:10.1002/hep.25965 · Cited by 138 · see citing works

Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture

Francque, S., Laleman, W., Verbeke, L., Steenkiste, C. V., Casteleyn, C. R., Kwanten, W. J., Dyck, C. V., D'Hondt, M., Ramon, A., Vermeulen, W., et al. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.103 · Cited by 136 · see citing works

Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease

Coulon, S., Francque, S., Colle, I. O., Verrijken, A., Blomme, B., Heindryckx, F., Munter, S. D., Prawitt, J., Caron, S., Staels, B., et al. (2012) · Cytokine · doi:10.1016/j.cyto.2012.05.001 · Cited by 136 · see citing works

Angiopoietin‐2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease

Lefere, S., de Velde, F. V., Hoorens, A., Raevens, S., Campenhout, S. V., Vandierendonck, A., Neyt, S., Vandeghinste, B., Vanhove, C., Debbaut, C., et al. (2018) · Hepatology · doi:10.1002/hep.30294 · Cited by 134 · see citing works

The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver

Wilkinson, A. L., Qurashi, M., & Shetty, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00990 · Cited by 121 · see citing works

Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis

Li, H., Zhou, Y., Wang, H., Zhang, M., Qiu, P., Zhang, M., Zhang, R., Zhao, Q., & Liu, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01169 · Cited by 114 · see citing works

Resolution of liver fibrosis requires myeloid cell–driven sinusoidal angiogenesis

Kantari‐Mimoun, C., Castells, M., Klose, R., Meinecke, A., Lemberger, U. J., Rautou, P., Pinot‐Roussel, H., Badoual, C., Schrödter, K., Österreicher, C. H., et al. (2014) · Hepatology · doi:10.1002/hep.27635 · Cited by 112 · see citing works

Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin β1

Dong, Y., Xie, X., Wang, Z., Hu, C., Zheng, Q., Wang, Y., Chen, R., Xue, T., Chen, J., Gao, D., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.079 · Cited by 110 · see citing works

The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers

Bartneck, M., Schrammen, P. L., Möckel, D., Govaere, O., Liepelt, A., Krenkel, O., Ergen, C., McCain, M. V., Eulberg, D., Luedde, T., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.007 · Cited by 107 · see citing works

Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment

Raevens, S., Geerts, A. M., Steenkiste, C. V., Verhelst, X., Vlierberghe, H. V., & Colle, I. O. (2015) · Liver International · doi:10.1111/liv.12791 · Cited by 104 · see citing works

Histidine‐rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease

Bartneck, M., Fech, V., Ehling, J., Govaere, O., Warzecha, K. T., Hittatiya, K., Vucur, M., Gautheron, J., Luedde, T., Trautwein, C., et al. (2016) · Hepatology · doi:10.1002/hep.28418 · Cited by 101 · see citing works

A strategy of vascular‐targeted therapy for liver fibrosis

Yuan, L., Dong, M., Liu, Z., Xu, M., Huang, Z., Liu, H., Gao, Y., & Zhou, W. (2021) · Hepatology · doi:10.1002/hep.32299 · Cited by 100 · see citing works

Platelets as Key Factors in Hepatocellular Carcinoma

Pavlovic, N., Rani, B., Gerwins, P., & Heindryckx, F. (2019) · Cancers · doi:10.3390/cancers11071022 · Cited by 97 · see citing works

Review of angiogenesis in hepatocellular carcinoma

Muto, J., Shirabe, K., Sugimachi, K., & Maehara, Y. (2014) · Hepatology Research · doi:10.1111/hepr.12310 · Cited by 95 · see citing works

The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis

Hintermann, E., & Christen, U. (2019) · Cells · doi:10.3390/cells8121503 · Cited by 87 · see citing works

New insights on the role of vascular endothelial growth factor in biliary pathophysiology

Mariotti, V., Fiorotto, R., Cadamuro, M., Fabris, L., & Strazzabosco, M. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100251 · Cited by 87 · see citing works

The role of chemokines in acute and chronic hepatitis C infection

Fahey, S., Dempsey, E., & Long, A. (2013) · Cellular and Molecular Immunology · doi:10.1038/cmi.2013.37 · Cited by 80 · see citing works

Targeting the tumor stroma in hepatocellular carcinoma

Heindryckx, F. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v7.i2.165 · Cited by 79 · see citing works

Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma

Li, H. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1842732 · Cited by 76 · see citing works

Decellularized hepatic extracellular matrix hydrogel attenuates hepatic stellate cell activation and liver fibrosis

Hussein, K. H., Park, K.-M., Yu, L., Kwak, H.-H., & Woo, H.-M. (2020) · Materials Science and Engineering: C · doi:10.1016/j.msec.2020.111160 · Cited by 75 · see citing works

Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis

Feng, J., Wang, C., Liu, T., Li, J., Wu, L., Yu, Q., Li, S., Zhou, Y., Zhang, J., Chen, J., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14543 · Cited by 71 · see citing works

Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma

Ponziani, F. R., Nicoletti, A., Gasbarrini, A., & Pompili, M. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919848184 · Cited by 69 · see citing works

Stratification of Patients With Liver Fibrosis Using Dual-Energy CT

Lamb, P., Sahani, D. V., Fuentes, J. M., Patiño, M., Ghosh, A., & Mendonça, P. R. S. (2014) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2014.2353044 · Cited by 69 · see citing works

Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease

Lefere, S., Steenkiste, C. V., Verhelst, X., Vlierberghe, H. V., Devisscher, L., & Geerts, A. M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2222-1 · Cited by 68 · see citing works

Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells

Wang, L., Feng, Y., Xie, X., Wu, H., Su, X. N., Qi, J., Xin, W., Gao, L., Zhang, Y., Shah, V. H., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.050 · Cited by 66 · see citing works

Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet

Mousavi, S. N., Faghihi, A., Motaghinejad, M., Shiasi, M., Imanparast, F., Amiri, H. L., & Shidfar, F. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-1059-2 · Cited by 66 · see citing works

Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression

Takino, J. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i15.1781 · Cited by 64 · see citing works

Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis

Yao, Q., Lin, Y.-Z., Li, X., Shen, X., Wang, J., & Tu, C. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.06.240 · Cited by 64 · see citing works

Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature

Nomden, M., Beljaars, L., Verkade, H. J., Hulscher, J. B. F., & Olinga, P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.617261 · Cited by 64 · see citing works

Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?

Gnoni, A., Santini, D., Scartozzi, M., Russo, A. D., Licchetta, A., Palmieri, V. O., Lupo, L., Faloppi, L., Palasciano, G., Memeo, V., et al. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1071354 · Cited by 62 · see citing works

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma

Govaere, O., Petz, M., Wouters, J., Vandewynckel, Y.-P., Scott, E. J., Topal, B., Nevens, F., Verslype, C., Anstee, Q. M., Vlierberghe, H. V., et al. (2017) · Oncogene · doi:10.1038/onc.2017.260 · Cited by 62 · see citing works

Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines

Jardim‐Perassi, B. V., Lourenço, M. R., Doho, G. M., Grigolo, I. H., Gelaleti, G. B., Ferreira, L. C., Borin, T. F., Moschetta, M. G., & Zuccari, D. A. P. D. C. (2016) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520615666150511094201 · Cited by 60 · see citing works

Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment

Zadorozhna, M., Gioia, S. D., Conese, M., & Mangieri, D. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05290-0 · Cited by 57 · see citing works

Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients

Lv, Z., Weng, X., Du, C., Zhang, C., Xiao, H., Cai, X., Ye, S., Cheng, J., Ding, C., Xie, H., et al. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22345 · Cited by 55 · see citing works

Icariin protects against thioacetamide-induced liver fibrosis in rats: Implication of anti-angiogenic and anti-autophagic properties

Algandaby, M. M., Breikaa, R. M., Eid, B. G., Neamatallah, T., Abdel‐Naim, A. B., & Ashour, O. M. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.02.016 · Cited by 55 · see citing works

Curcumol attenuates liver sinusoidal endothelial cell angiogenesis via regulating Glis‐PROX1‐HIF‐1α in liver fibrosis

Xiang, Y., Wang, Z., Kai, J., Wang, F., Jia, Y., Wang, S., Tan, S., Shen, X., Chen, A., Shao, J., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12762 · Cited by 54 · see citing works

Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma

Barbier, C. E., Heindryckx, F., & Lennernäs, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313051 · Cited by 54 · see citing works

A Huaier polysaccharide restrains hepatocellular carcinoma growth and metastasis by suppression angiogenesis

Li, C., Wu, X., Zhang, H., Yang, G., Hao, M., Sheng, S., Sun, Y., Long, J., Hu, C., Sun, X., et al. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.01.016 · Cited by 54 · see citing works

4-Methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis

Piccioni, F., Fiore, E. J., Bayo, J., Atorrasagasti, C., Peixoto, E., Rizzo, M., Malvicini, M., Tirado‐González, I., García, M. G., Alaniz, L. D., et al. (2015) · Glycobiology · doi:10.1093/glycob/cwv023 · Cited by 54 · see citing works

Hypoxia-induced secretion of platelet-derived growth factor-BB by hepatocellular carcinoma cells increases activated hepatic stellate cell proliferation, migration and expression of vascular endothelial growth factor-A

Lü, Y., Lin, N., Chen, Z., & Xu, R. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2689 · Cited by 53 · see citing works

Role of Angiogenesis in the Pathogenesis of NAFLD

Lei, L., Mourabit, H. E., Housset, C., Cadoret, A., & Lemoinne, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071338 · Cited by 53 · see citing works

Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization

Deng, W., Gu, X., Lu, Y., Gu, C., Zheng, Y., Zhang, Z., Chen, L., Yao, Z., & Li, L. (2011) · Angiogenesis · doi:10.1007/s10456-011-9244-y · Cited by 52 · see citing works

Kinsenoside screening with a microfluidic chip attenuates gouty arthritis through inactivating NF-κB signaling in macrophages and protecting endothelial cells

Han, Q., Bing, W., Di, Y., Hua, L., Li, S., Yu-hua, Z., Han, X., Wang, Y., Fan, Q., Shih-mo, Y., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.255 · Cited by 51 · see citing works

Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating AMP-activated protein kinase

Li, Z., Ding, Q., Ling, L., Wu, Y., Meng, D., Li, X., & Zhang, C. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i7.819 · Cited by 51 · see citing works

The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis

Du, W., & Wang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.936196 · Cited by 51 · see citing works

Tumor Endothelial Inflammation Predicts Clinical Outcome in Diverse Human Cancers

Pitroda, S. P., Zhou, T., Sweis, R. F., Filippo, M., Labay, E., Beckett, M. A., Mauceri, H. J., Liang, H. L., Darga, T. E., Perakis, S. O., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046104 · Cited by 50 · see citing works

Efficacy of Coccinia grandis against monosodium glutamate induced hepato-cardiac anomalies by inhibiting NF-kB and caspase 3 mediated signalling in rat model

Banerjee, A., Mukherjee, S., & Maji, B. K. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211010895 · Cited by 53 · see citing works

Placental Growth Factor Contributes to Liver Inflammation, Angiogenesis, Fibrosis in Mice by Promoting Hepatic Macrophage Recruitment and Activation

Li, X., Jin, Q., Yao, Q., Zhou, Y., Zou, Y., Li, Z., Zhang, S., & Tu, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00801 · Cited by 48 · see citing works

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells

Huang, Y., Feng, H., Kan, T., Huang, B., Zhang, M., Li, Y., Shi, C., Wu, M., Luo, Y., Yang, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073492 · Cited by 47 · see citing works

Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background

Ganzetti, G. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i2.120 · Cited by 47 · see citing works

Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma

Li, H. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.07.006 · Cited by 47 · see citing works

Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies

Selimović, D., El‐Khattouti, A., Ghozlan, H. A., Haïkel, Y., Abdel-Kader, O., & Hassan, M. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i12.342 · Cited by 46 · see citing works

Characterization of Hepatocellular Carcinoma Related Genes and Metabolites in Human Nonalcoholic Fatty Liver Disease

Clarke, J., Novák, P., Lake, A. D., Shipkova, P. A., Aranı́bar, N., Robertson, D. G., Severson, P. L., Reily, M. D., Futscher, B. W., Lehman‐McKeeman, L. D., et al. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2873-9 · Cited by 45 · see citing works

Update on implications and mechanisms of angiogenesis in liver fibrosis

Zhang, Z., Zhang, F., Lu, Y., & Zheng, S. (2014) · Hepatology Research · doi:10.1111/hepr.12415 · Cited by 44 · see citing works

The role of macrophages in obesity-driven chronic liver disease

Devisscher, L., Verhelst, X., Colle, I. O., Vlierberghe, H. V., & Geerts, A. M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ru0116-016r · Cited by 44 · see citing works

Differential Roles of Angiogenesis in the Induction of Fibrogenesis and the Resolution of Fibrosis in Liver

Park, S., Kim, J., Kim, J., Lim, C. W., & Kim, B. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00325 · Cited by 43 · see citing works

Carthami flos extract against carbon tetrachloride-induced liver fibrosis via alleviating angiogenesis in mice

Xue, X., Zhao, X., Wang, J., Wang, C., Ma, C., Zhang, Y., Li, Y., & Peng, C. Y. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154517 · Cited by 42 · see citing works

Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor

Oya, H., Kanda, M., Sugimoto, H., Shimizu, D., Takami, H., Hibino, S., Hashimoto, R., Okamura, Y., Yamada, S., Fujii, T., et al. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0993-4 · Cited by 41 · see citing works

Effects of microRNA-126 on cell proliferation, apoptosis and tumor angiogenesis via the down-regulating ERK signaling pathway by targeting EGFL7 in hepatocellular carcinoma

Cheng, G., Fang, J., Li, G., Liu, H.-H., & Liu, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.17283 · Cited by 41 · see citing works

Modeling angiogenesis with micro- and nanotechnology

Chen, L.-J., & Kaji, H. (2017) · Lab on a Chip · doi:10.1039/c7lc00774d · Cited by 41 · see citing works

Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease

Wang, X., & Peng, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.655557 · Cited by 40 · see citing works

Persistent fibrosis in the liver of choline-deficient and iron-supplemented l-amino acid-defined diet-induced nonalcoholic steatohepatitis rat due to continuing oxidative stress after choline supplementation

Takeuchi-Yorimoto, A., Noto, T., Yamada, A., Miyamae, Y., Oishi, Y., & Matsumoto, M. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.027 · Cited by 39 · see citing works

ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver

Schmid, C. D., Olsavszky, V., Reinhart, M., Weyer, V., Trogisch, F. A., Sticht, C., Winkler, M., Kürschner, S. W., Hoffmann, J., Ola, R., et al. (2022) · Hepatology · doi:10.1002/hep.32641 · Cited by 38 · see citing works

Aqueous Date Flesh or Pits Extract Attenuates Liver Fibrosis via Suppression of Hepatic Stellate Cell Activation and Reduction of Inflammatory Cytokines, Transforming Growth Factor-β1 and Angiogenic Markers in Carbon Tetrachloride-Intoxicated Rats

Al-Rasheed, N. M., Attia, H., Mohamad, R. A., Al‐Rasheed, N. M., Alamin, M. A., & Alonazi, A. S. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/247357 · Cited by 37 · see citing works

Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data

Ichikawa, S., Motosugi, U., Enomoto, N., & Onishi, H. (2018) · European Radiology · doi:10.1007/s00330-018-5640-7 · Cited by 37 · see citing works

The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis

van der Graaff, D., Kwanten, W. J., & Francque, S. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.11.014 · Cited by 37 · see citing works

Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis

Hansen, H. H., Pors, S. E., Andersen, M. W., Vyberg, M., Nøhr-Meldgaard, J., Nielsen, M. H., Oró, D., Madsen, M. R., Lewińska, M., Møllerhøj, M. B., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-50328-5 · Cited by 37 · see citing works

Molecular Mechanism of Aflatoxin-Induced Hepatocellular Carcinoma Derived from a Bioinformatics Analysis

Cai, P., Zheng, H., She, J., Feng, N., Zou, H., Gu, J., Yuan, Y., Liu, X., Liu, Z., & Bian, J. (2020) · Toxins · doi:10.3390/toxins12030203 · Cited by 36 · see citing works

Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease

Li, X., Yao, Q., Liu, H., Jin, Q., Xu, B., Zhang, S., & Tu, C. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13158 · Cited by 35 · see citing works

The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease

Minciună, I., Taru, M. G., Procopeț, B., & Ştefănescu, H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051406 · Cited by 34 · see citing works

Angiogenesis: a phenomenon which aggravates chronic liver disease progression

Kukla, M. (2012) · Hepatology International · doi:10.1007/s12072-012-9391-2 · Cited by 34 · see citing works

Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression

Joo, Y. Y., Jang, J. W., Lee, S. W., Yoo, S. H., Kwon, J. H., Nam, S. W., Bae, S. H., Choi, J. Y., & Yoon, S. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45537-w · Cited by 33 · see citing works

Fuzhenghuayu Decoction ameliorates hepatic fibrosis by attenuating experimental sinusoidal capillarization and liver angiogenesis

Liu, H., Lv, J., Zhao, Z., Xiong, A., Tan, Y., Glenn, J. S., Tao, Y., Weng, H., & Liu, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-54663-4 · Cited by 33 · see citing works

The Role of Fas/Fas Ligand System in the Pathogenesis of Liver Cirrhosis and Hepatocellular Carcinoma

Hammam, O. A., Mahmoud, O., Zahran, M. Y., Aly, S., Hosny, K., Helmy, A., & Anas, A. (2012) · Hepatitis Monthly · doi:10.5812/hepatmon.6132 · Cited by 33 · see citing works

Hypoxia-inducible factor 1α/IL-6 axis in activated hepatic stellate cells aggravates liver fibrosis

Kou, K., Li, S., Qiu, W., Fan, Z., Lv, G., & Lv, G. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.02.032 · Cited by 32 · see citing works

The effects of Tao-Hong-Si-Wu on hepatic necroinflammatory activity and fibrosis in a murine model of chronic liver disease

Xi, S., Shi, M., Jiang, X., Minuk, G. Y., Cheng, Y., Peng, Y., Gong, Y., Xu, Y., Wang, X., Yang, J., et al. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.01.030 · Cited by 32 · see citing works

Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin‐1

Lin, N., Meng, L., Lin, J., Chen, S., Zhang, P., Chen, Q., & Lin, Y. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29380 · Cited by 32 · see citing works

Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma

Chen, K.-D., Wang, C.-C., Tsai, M.-C., Wu, C.-H., Yang, H.-J., Chen, L.-Y., Nakano, T., Goto, S., Huang, K.-T., Hu, T.-H., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.212 · Cited by 31 · see citing works

The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention

Kaliora, A. C., Kokkinos, A. D., Diolintzi, A., Stoupaki, M. G., Gioxari, A., Kanellos, P. T., Dedoussis, G. V., Vlachogiannakos, J., Revenas, C., Ladas, S. D., et al. (2016) · Food & Function · doi:10.1039/c6fo01040g · Cited by 31 · see citing works

Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice

Kong, L., Li, H., Du, Y.-J., PEI, F.-H., Hu, Y., Zhao, L.-L., & Chen, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6325 · Cited by 31 · see citing works

Role of angiogenic factors/cell adhesion markers in serum of cirrhotic patients with hepatopulmonary syndrome

Raevens, S., Coulon, S., Steenkiste, C. V., Colman, R., Verhelst, X., Vlierberghe, H. V., Geerts, A. M., Perkmann, T., Horvatits, T., Fuhrmann, V., et al. (2014) · Liver International · doi:10.1111/liv.12579 · Cited by 31 · see citing works

Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma

Vandewynckel, Y., Laukens, D., Devisscher, L., Bogaerts, E., Paridaens, A., den Bussche, A. V., Raevens, S., Verhelst, X., Steenkiste, C. V., Jonckx, B., et al. (2016) · BMC Cancer · doi:10.1186/s12885-015-1990-6 · Cited by 31 · see citing works

A new model combining the liver/spleen volume ratio and classification of varices predicts HVPG in hepatitis B patients with cirrhosis

Yan, S.-P., Wu, H., Wang, G.-C., Chen, Y., Zhang, C., & Zhu, Q. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000269 · Cited by 31 · see citing works

Review article: the role of the microcirculation in liver cirrhosis

Davies, T., Wythe, S., O’Beirne, J. P., Martín, D., & Gilbert-Kawai, E. T. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14279 · Cited by 30 · see citing works

Protective Effects of Flavone from Tamarix aphylla against CCl4-Induced Liver Injury in Mice Mediated by Suppression of Oxidative Stress, Apoptosis and Angiogenesis

El‐Aarag, B., Khairy, A., Khalifa, S. A. M., & El-Seedi, H. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205215 · Cited by 30 · see citing works

Single-cell transcriptome analysis reveals liver injury induced by glyphosate in mice

Wu, J., Sun, X., Wu, C., Hong, X., Xie, L., Shi, Z., Zhao, L., Du, Q., Xiao, W. L., Sun, J., et al. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00426-z · Cited by 30 · see citing works

Hepatic Angiogenesis and Fibrogenesis in the Progression of Chronic Liver Diseases

Paternostro, C., Busletta, C., Cannito, S., Novo, E., & Parola, M. (2013) · Current Angiogenesis · doi:10.2174/22115528112019990001 · Cited by 3 · see citing works

Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases

Paternostro, C. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i3.281 · Cited by 113 · see citing works

Angiogenesis and liver fibrosis

Elpek, G. Ö. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.377 · Cited by 157 · see citing works

Angiogenesis in liver disease

Fernández, M., Semela, D., Bruix, J., Colle, I. O., Pinzani, M., & Bosch, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.011 · Cited by 598 · see citing works

Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma

Li, H. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1842732 · Cited by 76 · see citing works